Observe Medical ASA (FRA:OM50) LT-Debt-to-Total-Asset: 0.20 (As of Dec. 2025)

What is Observe Medical ASA LT-Debt-to-Total-Asset?

Observe Medical ASA FRA:OM50 -1.54% 32 LT-Debt-to-Total-Asset is 0.20 as of Dec. 2025. GuruFocus rates FRA:OM50 with a GF Score™ of 32/100 and a GF Value™ of €0.02. The stock has 5 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Observe Medical ASA's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.20.

Observe Medical ASA's long-term debt to total assets ratio declined from Dec. 2024 (0.43) to Dec. 2025 (0.20). It may suggest that Observe Medical ASA is progressively becoming less dependent on debt to grow their business.

Observe Medical ASA (FRA:OM50) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Observe Medical ASA LT-Debt-to-Total-Asset Related Terms

Observe Medical ASA LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Observe Medical ASA's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Observe Medical ASA LT-Debt-to-Total-Asset Chart

Observe Medical ASA Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

0.29

0.43

0.20

Observe Medical ASA Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial													0.29	0.00	0.43	0.47	0.20

32GF Score

Observe Medical ASA FRA:OM50

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Observe Medical ASA LT-Debt-to-Total-Asset Calculation

Observe Medical ASA's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	1.683	/	8.548
	=	0.20

Observe Medical ASA's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )	/	Total Assets (Q: Dec. 2025 )
	=	1.683	/	8.548
	=	0.20

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.20 mean?

Observe Medical ASA (FRA:OM50) has a LT-Debt-to-Total-Asset of 0.20 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Observe Medical ASA and its competitors.

Is Observe Medical ASA's LT-Debt-to-Total-Asset too high?

Observe Medical ASA's current LT-Debt-to-Total-Asset is 0.20. Overall, Observe Medical ASA has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.

How does Observe Medical ASA's LT-Debt-to-Total-Asset compare to ABT and SYK?

Observe Medical ASA's LT-Debt-to-Total-Asset of 0.20 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?

A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Observe Medical ASA and its competitors. Observe Medical ASA's current LT-Debt-to-Total-Asset is 0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Observe Medical ASA stock overvalued right now?

Observe Medical ASA (FRA:OM50) has a current LT-Debt-to-Total-Asset of 0.20. The stock's GF Value™ is €0.02, compared to a current price of €0.09 — trading 347% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.20. Observe Medical ASA's overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Observe Medical ASA (FRA:OM50), the current LT-Debt-to-Total-Asset is 0.20 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Observe Medical ASA (FRA:OM50) Overvalued in 2026?

Based on GuruFocus' analysis, Observe Medical ASA stock appears to be overvalued. The current stock price of €0.09 is trading 347% above its estimated GF Value™ of €0.02.

Key valuation signals for FRA:OM50:

LT-Debt-to-Total-Asset: 0.20
GF Value™: €0.02 vs. price of €0.09 (347% above fair value)
GF Score™: 32/100 with 5 warning signs

No single metric tells the full story. See the FRA:OM50 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Observe Medical ASA Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OSL:LIFE OSL:GENT ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760 STE ZBH XSWX:SOON LSE:SN.PEN SHSE:688271 GMED TSE:7733

Other Exchanges OBSRV:Norway

Address Dronning Eufemias gate 16, Oslo, NOR, 0191

Website https://www.observemedical.com

Observe Medical ASA is a Nordic medtech company focused on the development, commercialization, and scaling of medical technologies for the healthcare markets. The company's portfolio of proprietary products consists of: Sippi, a CE marked digitalized system for urine output measurement, the UnoMeter portfolio consisting of manual urine output measurement products and solutions for measuring intra-abdominal pressure. The company operates internationally through subsidiaries in Norway, Sweden and Denmark.

32GF Score

Get the complete analysis for FRA:OM50

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.09

Price

€0.02

GF Value

View FRA:OM50 Analysis

See LT-Debt-to-Total-Asset data for all stocks →